[Vulvar squamous cell hyperplasia and lichen sclerosus et atrophicus: clinical picture, morphology and treatment].
Treatment of the vulvar squamous cell hyperplasia and lichen sclerosus et atrophicus by topical using of corticosteroids and 2% testosterone ointment. The period of observation was from 6 months to 18 months. All patients showed clinical improvement or full regression depending on the period of disease. In all cases histopathologic examination was performed.
Rotsztejn
H
H
Instytut Centrum Zdrowia Matki Polki, Gabinet Dermatologiczny Przychodni Połozniczo-Ginekologicznej, Lódź.
Krawczyk
T
T
Bartodziej
U
U
D000287:Administration, Topical; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002990:Clobetasol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D018459:Lichen Sclerosus et Atrophicus / Q000188:drug therapy* / Q000473:pathology*; D008875:Middle Aged; D018307:Neoplasms, Squamous Cell / Q000188:drug therapy* / Q000473:pathology*; D009824:Ointments; D013739:Testosterone / Q000627:therapeutic use*; D014846:Vulvar Neoplasms / Q000188:drug therapy* / Q000473:pathology*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009824:Ointments; D013739:Testosterone; D002990:Clobetasol
Rozrost płaskonabłonkowy oraz liszaj twardzinowy i zanikowy sromu--obraz kliniczny, morfologiczny i leczenie.